DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ rallied 1.00% to $805.97 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.65% to 7,798.99 and the Dow Jones Industrial Average rising 0.13% to 53,839.99.
This was the stock's second consecutive day of gains.
Regeneron Pharmaceuticals Inc. closed 1.84% below its 52-week high of $821.11, which the company reached on January 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Amgen Inc. $(AMGN)$ rose 0.40% to $417.84, Moderna Inc. (MRNA) fell 0.03% to $63.65, and Gilead Sciences Inc. (GILD) rose 1.67% to $138.14.
Trading volume (695,679) remained 231,294 below its 50-day average volume of 926,973.
Data source: Dow Jones Market Data, FactSet. Data compiled August 13, 2026.